Duodenal Jejunal Bypass for Type 2 Diabetes (DJBD)
NCT00487526 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2007-07-11
Summary
Study the effect of Duodenal jejunal bypass on human adults with type 2 diabetes.
Conditions
Interventions
- PROCEDURE
-
duodenal jejunal bypass
Sponsors & Collaborators
-
Ferzli, George S., M.D. F.A.C.S.
lead INDIV
Principal Investigators
-
George S Ferzli, MD F.A.C.S · SUNY Downstate
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 20 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-06-30
Countries
- Dominican Republic
Study Locations
More Related Trials
-
Surgical Treatment of Type 2 Diabetes Mellitus in <35 Body Mass Index (BMI)
NCT00996294 ·Status: UNKNOWN ·Phase: NA
-
Prospective Randomized Trials of Gastric Bypass Surgery in Patients With Type II Diabetes Mellitus
NCT00540462 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effects of Glycemic Optimization Before Gastric Bypass Surgery
NCT01353118 ·Status: COMPLETED ·Phase: NA
-
Effect of Biliopancreatic Diversion on Glucose Homeostasis
NCT03111953 ·Status: COMPLETED ·Phase: NA
-
Multicentric Prospective Randomized Trial on Surgery Versus Standard Medical Care in Type 2 Diabetic Patients BMI 30-35
NCT01041768 ·Status: UNKNOWN ·Phase: NA
-
Surgical Treatment in Diabetic Patients With Grade 1 Obesity
NCT01857076 ·Status: COMPLETED ·Phase: NA
-
The Surgical Treatment of Type 2 Diabetes Mellitus in Non-Morbidly Obese Patients: A Community Hospital Study
NCT01323114 ·Status: UNKNOWN ·Phase: NA
-
Mechanisms Behind Antidiabetic Effects by Gastric By-pass
NCT01708096 ·Status: COMPLETED ·Phase: NA
-
Bariatric Surgery for the Treatment of Type 2 Diabetes - Clinical Effects and Underlying Mechanisms
NCT02729246 ·Status: COMPLETED ·Phase: NA
-
Prevention and Treatment Of Diabetes Complications With Gastric Surgery or Intensive Medicines
NCT01974544 ·Status: UNKNOWN ·Phase: NA
-
Metabolic Surgery; Gastric Bypass vs Sleeve Gastrectomy; Efects Over Type 2 DM With Bad Metabolic Control (MSO1CT)
NCT03891056 ·Status: UNKNOWN ·Phase: NA
-
Impact of GBS on CVD in Type 2 Diabetes Mellitus
NCT00787670 ·Status: COMPLETED ·Phase: NA
-
Diet and Medical Therapy Versus Bariatric Surgery in Type 2 Diabetes
NCT00888836 ·Status: COMPLETED ·Phase: NA
-
Elucidating the Mechanism of Remission of Type 2 Diabetes in Morbid Obese Patients After Bariatric Surgery
NCT03038373 ·Status: UNKNOWN
-
Prospective Controlled Trial on Surgical Treatment of Type 2 Diabetes Patients With BMI 25-30 by Means of Biliopancreatic Diversion
NCT01046994 ·Status: UNKNOWN ·Phase: PHASE3
-
Comparisons of Metabolic Effect of Sleeve Gastrectomy With Duodenojejunal Bypass and Sleeve Gastrectomy (MEDUSA): A Multicenter Randomized Controlled Trial
NCT05211375 ·Status: RECRUITING ·Phase: PHASE3
-
Adolescent Gastric By-pass and Diabetic Precursors
NCT00360373 ·Status: COMPLETED
-
Medically Reproducing Bariatric Surgery
NCT03225209 ·Status: COMPLETED ·Phase: PHASE2
-
Adipose Tissue Dysfunction in Type 2 Diabetes and Its Reversibility by Bariatric Surgery
NCT05291013 ·Status: UNKNOWN ·Phase: NA
-
Effect of Bariatric Surgery on Brain Insulin Sensitivity
NCT03705923 ·Status: TERMINATED ·Phase: NA
-
Mitigation of Type 2 Diabetes by Partial Ileal Bypass
NCT02493374 ·Status: WITHDRAWN
-
Impact of Gastric Bypass Surgery on Risk of CVD in Type 2 Diabetes Mellitus
NCT00444392 ·Status: COMPLETED ·Phase: PHASE3
-
Early Sleeve Gastrectomy In New Onset Diabetic Obese Patients
NCT02488733 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Restoration of Beta Cell Function and Cardiovascular Parameters in Relation to Adipoinsular and Enteroinsular Axes After Gastric Bypass Surgery
NCT01271062 ·Status: COMPLETED ·Phase: NA
-
Diabetes Resolution and Hormone Changes After BPDLL and LSG
NCT01481675 ·Status: COMPLETED